These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15243073

  • 1. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.
    Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2004 Jul; 42(7):3142-6. PubMed ID: 15243073
    [Abstract] [Full Text] [Related]

  • 2. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M, Global Antifungal Surveillance Group.
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
    [Abstract] [Full Text] [Related]

  • 3. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Nagy E, Dobiasova S, Rinaldi M, Barton R, Veselov A, Global Antifungal Surveillance Group.
    J Clin Microbiol; 2008 Feb; 46(2):515-21. PubMed ID: 18077633
    [Abstract] [Full Text] [Related]

  • 4. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
    Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA, SENTRY Participant Group.
    J Clin Microbiol; 2001 Sep; 39(9):3254-9. PubMed ID: 11526159
    [Abstract] [Full Text] [Related]

  • 5. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM, Elizondo M, Ayala J.
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [Abstract] [Full Text] [Related]

  • 6. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
    Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ.
    J Clin Microbiol; 2005 May; 43(5):2163-7. PubMed ID: 15872236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ng KP, Colombo A, Finquelievich J, Barnes R, Wadula J, Global Antifungal Surveillance Group.
    J Clin Microbiol; 2008 Mar; 46(3):842-9. PubMed ID: 18199791
    [Abstract] [Full Text] [Related]

  • 9. Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
    Spreghini E, Maida CM, Tomassetti S, Orlando F, Giannini D, Milici ME, Scalise G, Barchiesi F.
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1929-33. PubMed ID: 18391037
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M, Scaltrito MM, Morace G, GISIA-2 Group.
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [Abstract] [Full Text] [Related]

  • 11. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC, Chen YH, Chen YC, Lu PL.
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Candida nivariensis, Isolated in a Teaching Hospital in Poland.
    Sikora M, Kuthan R, Piskorska-Malolepsza K, Golas-Pradzynska M, Domański D, Augustynowicz-Kopeć E, Swoboda-Kopec E.
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [Abstract] [Full Text] [Related]

  • 18. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N, Alem N.
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT, Cañadas J, García-Martos P, Marín P, García-Tapia A, Rodríguez J.
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [Abstract] [Full Text] [Related]

  • 20. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA, Denardi LB, Bandeira LA, Antunes MS, Santurio JM, Severo LC, Alves SH.
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.